SHA:603707 Revenue

Nanjing King-Friend Biochemical Pharmaceutical had revenue of 885.22M CNY in the quarter ending March 31, 2025, a decrease of -11.85%. This brings the company's revenue in the last twelve months to 3.80B, up 4.86% year-over-year. In the year 2024, Nanjing King-Friend Biochemical Pharmaceutical had annual revenue of 3.92B, down -0.20%.

Revenue (ttm)

3.80B

Revenue Growth

+4.86%

P/S Ratio

4.58

Revenue / Employee

2.80M

Employees

1,360

Market Cap

17.43B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	3.92B	-7.80M	-0.20%
Dec 31, 2023	3.93B	218.67M	5.89%
Dec 31, 2022	3.71B	26.03M	0.71%
Dec 31, 2021	3.69B	771.81M	26.48%
Dec 31, 2020	2.91B	445.21M	18.03%
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro
Dec 31, 2016	Pro	Pro	Pro
Dec 31, 2015	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Jiangsu Hengrui Medicine	29.19B
Shenzhen Mindray Bio-Medical Electronics	35.59B
WuXi AppTec	39.59B
Zhangzhou Pientzehuang Pharmaceutical.,	10.76B
Aier Eye Hospital Group	21.81B
Sichuan Biokin Pharmaceutical	5.82B
Shanghai United Imaging Healthcare	10.43B
Yunnan Baiyao Group Co.,Ltd	40.10B

Revenue Rankings